Navigation Links
Breakthrough in understanding the genetics of high blood pressure
Date:11/9/2011

A researcher from the University of Leicester's Department of Cardiovascular Sciences has been involved in a ground-breaking study into the causes of high blood pressure.

The study, published in the academic journal Hypertension, analysed genetic material in human kidneys in a search for genes that might contribute to high blood pressure. The findings open up new avenues for future investigation into the causes of high blood pressure in humans.

The study identified key genes, messenger RNAs and micro RNAs present in the kidneys that may contribute to human hypertension. It also uncovered two microRNAs that contribute to the regulation of renin a hormone long thought to play to part in controlling blood pressure.

Although scientists have long known that the kidneys play a role in regulating blood pressure, this is the first time that key genes involved in the process have been identified through a large, comprehensive gene expression analysis of the human kidneys. It is also the first time that researchers have identified miRNAs that control the expression of the hormone renin.

The scientists studied tissue samples from the kidneys of 15 male hypertensive patients (patients with high blood pressure) and 7 male patients with normal blood pressure, and compared their messenger RNA (mRNA) and micro RNA (miRNA).

Messenger RNA (mRNA) is a single-stranded molecule that helps in the production of protein from DNA. Genetic information is copied from DNA to mRNA strands, which provide a template from which the cell can make new proteins. MicroRNA (miRNA) is a very small molecule that helps regulate the process of converting mRNA into proteins.

The study was co-authored by the University of Leicester's Dr Maciej Tomaszewski, Senior Clinical Lecturer in Cardiovascular Medicine in the Department of Cardiovascular Sciences, and a Consultant Physician in Leicester Blood Pressure Clinic - European Centre of Excellence.

Dr Tomaszewski commented: "I am very excited about this publication. Renin is one of the most important contributors to blood pressure regulation. The novel insights into its expression within the human kidney from this study open up new avenues for the development of new antihypertensive medications. The collection of hypertensive and normotensive kidneys is available for our studies in Leicester thanks to a long-term international collaboration. We will continue using this unique research resource in our further studies to decipher the genetic background of human hypertension."

Researchers described the discovery of these miRNAs as "the first real evidence to implicate renin" as a cause of high blood pressure. The findings also indicate which genes and miRNAs are involved in renin production. This increased understanding of the mechanisms underlying hypertension could lead to innovative new treatments for high blood pressure.

Researchers used samples of human kidneys stored in the Silesian Renal Tissue Bank (SRTB), all of which came from Polish males individuals of white European ancestry. The SRTB stores human kidney samples for use in genetic research into cardiovascular diseases. Samples were selected from 15 patients known to have high blood pressure, along with 7 patients with normal blood pressure who were used as a control group for the study. The scientists used a range of techniques to study the genes, mRNAs and miRNAs present in the medulla (the inner part of the kidney) and the cortex (the outer part).


'/>"/>
Contact: Dr Maciej Tomaszewski
44-011-625-63019
University of Leicester
Source:Eurekalert

Related medicine news :

1. Northern Ireland company makes major breakthrough in cancer treatment
2. An important breakthrough at the IRCM associated with osteoporosis
3. Identification and management of breakthrough cancer pain remains a challenge
4. Childrens National researchers make breakthrough in understanding white matter development
5. UCSB develops breakthrough technology in identification of prostate cancer cells
6. Queens pioneers prostate cancer breakthrough
7. Breakthrough opens new avenues for hep C vaccine
8. Breakthrough in genetics of fibroids
9. Major ALS breakthrough
10. Researchers capture breakthrough data on cervical spine injuries
11. CT scans unleash a breakthrough in catching early stage lung cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether ... latter, setting the bar too high can result in disappointment, perhaps even self-loathing. However, ... their goal. , Research from PsychTests.com reveals that behind the tendency ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort to ... treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain management ... (SCD) is a disorder of the red blood cells, which can cause episodes of ...
(Date:6/24/2016)... ... ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys are recognized ... this recognition are considered among the top 2 percent of lawyers practicing within the ... this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. Bloom, Burt ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief ... a minimum wage raise to $12 an hour by 2020 and then adjusting it yearly ... lost value of the minimum wage, assure the wage floor does not erode again, and ...
(Date:6/24/2016)... York, NY (PRWEB) , ... June 24, 2016 ... ... publication Haute Living, is proud to recognize Dr. Barry M. Weintraub as a ... that “the most beautiful women in the world, and the most handsome men, ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on the ... announced that patient enrollment in its ongoing randomized ... has exceeded 50% of its 24-patient target. Capricor ... the third quarter of 2016, and to report ...
(Date:6/23/2016)... and INDIANAPOLIS , June 23, ... a Lilly Diabetes Tomorrow,s Leaders Scholarship is any indication, ... winners, announced today online at www.diabetesscholars.org by ... 1 diabetes stand in the way of academic and ... the Foundation,s scholarship program since 2012, and continues to ...
Breaking Medicine Technology: